Guidelines: Acute coronary syndrome (ACS)

[21] Cutlip D.E., Cove C.J., Irons D., Et al., Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedural outcomes, Am J Cardiol, 88, pp. 62-64, (2001)

[22] De Bono D., Simoons M.L., Tijssen J., Et al., Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: Results of a randomized double blind European Cooperative Study Group trial, Br Heart J, 67, pp. 122-128, (1992)

[23] De Lemos J.A., Antman E.M., Gibson C.M., McCabe C.H., Giugliano R.P., Murphy S.A., Coulter S.A., Anderson K., Scherer J., Frey M.J., Van Der Wieken R., Van De Werf F., Braunwald E., Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial, Circulation, 101, pp. 239-243, (2000)

[24] De Vreede J.J., Gorgels A.P., Verstraaten G.M., Vermeer F., Dassen W.R., Wellens H.J., Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis, J Am Coll Cardiol, 18, pp. 698-706, (1991)

[25] DeWood M.A., Spores J., Notske R., Et al., Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Engl J Med, 303, pp. 897-902, (1980)

[26] Dietz R., Rauch B., Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Z Kardiol, 92, pp. 501-521, (2003)

[27] Elad Y., French W.J., Shavelle D.M., Et al., Primary angioplasty and selection bias inpatients presenting late (> 12 h) after onset of chest pain and ST elevation myocardial infarction, J Am Coll Cardiol, 39, pp. 826-833, (2002)

[28] Ellis S.G., Da Silva E.R., Heyndrickx G., Et al., Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction, Circulation, 90, pp. 2280-2284, (1994)

[29] The ESPRIM trial: Short-term treatment of acute myocardial infarction with molsidomine, Lancet, 344, pp. 91-97, (1994)

[30] Fath-Ordoubadi F., Beatt K.J., Glucose-insulin-potassium therapy of acute myocardial infarction: An overview of randomized placebo-controlled trials, Circulation, 96, pp. 1152-1156, (1997)

[21] Cutlip D.E., Cove C.J., Irons D., Et al., Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedural outcomes, Am J Cardiol, 88, pp. 62-64, (2001)

[22] De Bono D., Simoons M.L., Tijssen J., Et al., Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: Results of a randomized double blind European Cooperative Study Group trial, Br Heart J, 67, pp. 122-128, (1992)

[23] De Lemos J.A., Antman E.M., Gibson C.M., McCabe C.H., Giugliano R.P., Murphy S.A., Coulter S.A., Anderson K., Scherer J., Frey M.J., Van Der Wieken R., Van De Werf F., Braunwald E., Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial, Circulation, 101, pp. 239-243, (2000)

[24] De Vreede J.J., Gorgels A.P., Verstraaten G.M., Vermeer F., Dassen W.R., Wellens H.J., Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis, J Am Coll Cardiol, 18, pp. 698-706, (1991)

[25] DeWood M.A., Spores J., Notske R., Et al., Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Engl J Med, 303, pp. 897-902, (1980)

[26] Dietz R., Rauch B., Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Z Kardiol, 92, pp. 501-521, (2003)

[27] Elad Y., French W.J., Shavelle D.M., Et al., Primary angioplasty and selection bias inpatients presenting late (> 12 h) after onset of chest pain and ST elevation myocardial infarction, J Am Coll Cardiol, 39, pp. 826-833, (2002)

[28] Ellis S.G., Da Silva E.R., Heyndrickx G., Et al., Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction, Circulation, 90, pp. 2280-2284, (1994)

[29] The ESPRIM trial: Short-term treatment of acute myocardial infarction with molsidomine, Lancet, 344, pp. 91-97, (1994)

[30] Fath-Ordoubadi F., Beatt K.J., Glucose-insulin-potassium therapy of acute myocardial infarction: An overview of randomized placebo-controlled trials, Circulation, 96, pp. 1152-1156, (1997)